Patents by Inventor Maria Cosenza

Maria Cosenza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11433069
    Abstract: The disclosure relates to pharmaceutical combinations comprising an HDAC6 selective inhibitor and a JAK1/2 inhibitor for the treatment of a cancer, such as a hematological cancer, in a subject in need thereof. Also provided herein are methods for treating a cancer in a subject in need thereof, comprising administering to the subject an effective amount of an HDAC6 selective inhibitor and a JAK1/2 inhibitor.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: September 6, 2022
    Assignee: University of Modena and Reggio Emilia
    Inventors: Samantha Pozzi, Maria Cosenza, Monica Civallero
  • Publication number: 20200383980
    Abstract: The disclosure relates to pharmaceutical combinations comprising an HDAC6 selective inhibitor and a JAK1/2 inhibitor for the treatment of a cancer, such as a hematological cancer, in a subject in need thereof. Also provided herein are methods for treating a cancer in a subject in need thereof, comprising administering to the subject an effective amount of an HDAC6 selective inhibitor and a JAK1/2 inhibitor.
    Type: Application
    Filed: November 30, 2018
    Publication date: December 10, 2020
    Inventors: Samantha Pozzi, Maria Cosenza, Monica Civallero
  • Patent number: 9937174
    Abstract: The invention relates to pharmaceutical combinations comprising an HDAC inhibitor and bendamustine; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions for treating lymphoma in a subject in need thereof.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: April 10, 2018
    Assignee: UNIVERSITY OF MODENA AND REGGIO EMILIA
    Inventors: Samantha Pozzi, Maria Cosenza
  • Publication number: 20160158232
    Abstract: The invention relates to pharmaceutical combinations comprising an HDAC inhibitor and bendamustine; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions for treating lymphoma in a subject in need thereof.
    Type: Application
    Filed: December 4, 2015
    Publication date: June 9, 2016
    Inventors: Samantha Pozzi, Maria Cosenza